Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction

Annals of Surgery

Volumn 259, Issue 4, 2014, Pages 687-693

  Khoo, Chin Meng ^a,b   Muehlbauer, Michael J ^a   Stevens, Robert D ^a   Pamuklar, Zehra ^a   Chen, Jiegen ^a   Newgard, Christopher B ^a   Torquati, Alfonso ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Amino acids; caloric restriction; morbid obesity; Roux en Y gastric bypass; type 2 diabetes

Indexed keywords

ACYLCARNITINE; ALANINE; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; INSULIN; ISOLEUCINE; LACTIC ACID; LEUCINE; METHIONINE; PHENYLALANINE; PROLINE; PYRUVIC ACID; SERINE; TYROSINE; VALINE;

ARTICLE; BARIATRIC SURGERY; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE PREDISPOSITION; HUMAN; HYPOGLYCEMIA; MASS SPECTROMETRY; MEAL; METABOLISM; METABOLITE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT; POSTPRANDIAL STATE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GASTROINTESTINAL HORMONES; HUMANS; HYPOGLYCEMIA; INSULIN; LAPAROSCOPY; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84895925031     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318296633f     Document Type: Article

References (25)

1. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236-242.
2. Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91:1735-1740.
3. Pournaras DJ, Osborne A, Hawkins SC, et al. The gut hormone response following Roux-en-Y gastric bypass: Cross-sectional and prospective study. Obes Surg. 2010;20:56-60.
4. Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518-2525.
5. Hansen EN, Tamboli RA, Isbell JM, et al. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol. 2011;300:G795-G802.
6. Salehi M, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60:2308-2314.
7. Kim SH, Liu TC, Abbasi F, et al. Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg. 2009;19:1550-1556.
8. GoldfineAB, Mun EC, Devine E, et al. Patientswith neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92:4678-4685.
9. Shaham O, Wei R, Wang TJ, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol. 2008;4:214.
10. Huffman KM, Redman LM, Landerman LR, et al. Caloric restriction alters the metabolic response to a mixed-meal: Results from a randomized, controlled trial. PLoS One. 2012;7:e28190.
11. Falken Y, Hellstrom PM, Holst JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: Role of gut peptides. J Clin Endocrinol Metab. 2011;96:2227-2235.
12. Laferrere B, Reilly D, Arias S, et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med. 2011;3:80re2.
13. Hansen JL, Freier EF. Direct assays of lactate, pyruvate, beta-hydroxybutyrate, and acetoacetate with a centrifugal analyzer. Clin Chem. 1978;24: 475-479.
14. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-326.
15. Selimoglu H, Duran C, Kiyici S, et al. Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects. Endocrine. 2009;36: 299-304.
16. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597-1604.
17. Menge BA, Gruber L, Jorgensen SM, et al. Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes. Diabetes. 2011;60:2160-2168.
18. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: Role of caloric restriction and weight loss. Obes Surg. 2005;15:462-473.
19. Floyd JC, Jr, Fajans SS, Conn JW, et al. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966;45:1487-1502.
20. Fieseler P, Bridenbaugh S, Nustede R, et al. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8. Am J Physiol. 1995;268:E949-E955.
21. Herrmann C, Goke R, Richter G, et al. Glucagon-like peptide-1 and glucosedependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion. 1995;56:117-126.
22. Cordier-Bussat M, Bernard C, Levenez F, et al. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes. 1998;47:1038-1045.
23. Tolhurst G, Reimann F, Gribble FM. Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol. 2009;587:27-32.
24. Thompson GB, Service FJ,Andrews JC, et al.Noninsulinoma pancreatogenous hypoglycemia syndrome: An update in 10 surgically treated patients. Surgery. 2000;128:937-944; discussion 944-945.
25. Camastra S, Gastaldelli A, Mari A, et al. Early and longer termeffects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54:2093-2102.